Skip to content

HAART reduces liver-related death risk, but hepatitis C infection increases risk, Italian study finds

HIV/HCV coinfected patients have poorer immunologic response to HIV treatment

Evidence that non-B strains of HIV being transmitted in the UK

Immune reconstitution syndrome risk highest in those commencing HIV therapy with advanced HIV disease

Clinton Foundation secures price cuts for efavirenz, abacavir and rapid HIV tests

Roche to share know-how in making protease inhibitors with poorest countries

Mortality falls in HIV/HCV coinfected Spaniards after the introduction of effective HIV treatment

ICAAC: Switch from AZT or d4T to tenofovir may improve blood fat levels

ICAAC: Switching from Combivir to Truvada has benefits for treatment-experienced patients